KCT0007432
Recruiting
未知
An observational study to evaluate the safety and efficacy of MegaDerm®Soft in patients who underwent breast reconstruction using the MegaDerm soft.
Soon Chun Hyang University Hospital Bucheon0 sites60 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Soon Chun Hyang University Hospital Bucheon
- Enrollment
- 60
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All subjects can participate in the clinical trial only when all of the following criteria are met.
- •? the patients who signed informed consent form
- •? Those aged 20 or over and under 65 years of age
- •? the patients who underwent breast reconstruction using Megaderm soft
Exclusion Criteria
- •if any of the following items apply, the subject is excluded from the clinical trial.
- •? overweight (BMI \=40 kg/m2\)
- •? Other patients who were judged to be difficult to participate in this study by the investigator
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 4
An observational study to evaluate the safety and efficacy of FOLFIRI / FOLFOX plus Cetuximab as first-line therapy inpatients with KRAS wild-type metastatic Colorectal cancerHealth Condition 1: null- Patients with KRAS wild-type metastatic Colorectal cancerCTRI/2010/091/000161Merck Specialities Pvt Limited5th Floor , Shivsagar EstateDr. Annie Besant RoadMumbai 400018100
Not yet recruiting
Not Applicable
An observational study to evaluate the safety and efficacy of lenvatinib plus pembrolizumab combination therapy for advanced or recurrent uterine cancer after use of platinum-based drugs(GOGO-EM4)JPRN-UMIN000049997Gynecologic Oncology Group of Osaka(GOGO)100
Recruiting
Phase 4
An Observational Study to evaluate the safety and efficacy of Cetuximab in combination with platinum-based chemotherapy, in the first-line therapy of recurrent/ metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)CTRI/2010/091/000170Merck Specialities Pvt Ltd5th Floor Shiv Sagar Estate, Dr. Aniie Besant Road, WorliMumbai 400018100
Recruiting
Not Applicable
An observational study to investigate the safety and efficacy of niraparib for Japanese patients with recurrent ovarian cancer: maintenance therapy for platinum-sensitive recurrent treatment and monotherapy for late-line treatmentOvarian cancer, fallopian tube cancer, primary peritoneal cancerJPRN-UMIN000046970Japanese Gynecologic Oncology Group180
Completed
Not Applicable
An observational study to investigate the safety and efficacy of niraparib maintenance therapy after primary chemotherapy for Japanese patients with advanced ovarian, fallopian tube, or primary peritoneal cancerovarian cancer, fallopian tube cancer, primary peritoneal cancerJPRN-UMIN000045931Japanese Gynecologic Oncology Group300